跳至主要内容
临床试验/CTRI/2021/02/031182
CTRI/2021/02/031182尚未招募2 期

Topical human immunoglobulin as adjunct therapy in dry eye disease

Dr RP Centre of Ophthalmic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. IOP 5 to 22 mmHg in each eye
  • 2. Tear film break up time (TFBUT) less than 7 seconds
  • 3. Schirmers test less than 9 mm per 5min
  • 4. Ocular Surface Disease Index (OSDI) score of at least 13.

排除标准

  • 1. Patients not consenting to participate and follow-up, presence of active systemic or ocular infections (including HBV, HCV & HIV) at the time of initiation of therapy and history of recent ocular surgery in the preceding six weeks will not be included in the study.
  • 2. Allergic to IVIG or any similar products, or excipients of IVIG eye drops 4 mg/ml.
  • 3. Use of contact lenses within the last 2-weeks prior to the baseline Visit.
  • 4. Pregnant or nursing/lactating
  • 5. Current diagnosis of any of the following ocular conditions: Acute allergic conjunctivitis,Active infection (e.g. bacterial, viral, protozoan or fungal infection of the cornea, conjunctiva, lacrimal gland, lacrimal sac or eyelids) , Active intraocular inflammation (e.g., retinitis, choroiditis, uveitis)
  • 6. A cognitive or psychiatric deficit that precludes informed consent or ability to perform
  • 7. Have active drug/alcohol dependence or abuse

研究者

发起方
Dr RP Centre of Ophthalmic Sciences

相似试验